WallStreetZenWallStreetZen

NASDAQ: BLAC
Bellevue Life Sciences Acquisition Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

BLAC earnings and revenue history

Current Revenue
$0.0
Current Earnings
$403.8k
Current Profit Margin
0%

BLAC Return on Equity

Current Company
-15.7%
Current Industry
-44.2%
Current Market
188%
BLAC's Return on Equity (-15.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BLAC announces earnings.

BLAC Return on Assets

Current Company
0.6%
Current Industry
0.7%
BLAC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BLAC Return on Capital Employed

Current Company
2.73%
Current Industry
-3.2%

BLAC vs Shell Company Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BLAC$0.00$944.59k$403.78kN/AN/A
BNIX$0.00$573.51k$65.38kN/AN/A
GMFI$0.00$1.66M$726.04kN/AN/A
HAIA$0.00$4.33M$4.33MN/A-53.94%
IGTA$0.00$732.40k$640.09kN/AN/A
View Top Shell Company Stocks

Bellevue Life Sciences Acquisition Earnings & Revenue FAQ

What were BLAC's earnings last quarter?

Bellevue Life Sciences Acquisition (NASDAQ: BLAC) reported Q4 2023 earnings per share (EPS) of -$0.01, up Infinity% year over year. Total Bellevue Life Sciences Acquisition earnings for the quarter were -$86.17 thousand. In the same quarter last year, Bellevue Life Sciences Acquisition's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Bellevue Life Sciences Acquisition stock.

What was BLAC's earnings growth in the past year?

As of Q2 2024, Bellevue Life Sciences Acquisition's earnings has grown year over year. Bellevue Life Sciences Acquisition's earnings in the past year totalled $403.78 thousand.

What was BLAC's revenue last quarter?

Bellevue Life Sciences Acquisition (NASDAQ: BLAC) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Bellevue Life Sciences Acquisition's revenue was $0.00.

What was BLAC's revenue growth in the past year?

As of Q2 2024, Bellevue Life Sciences Acquisition's revenue has grown null year over year. Bellevue Life Sciences Acquisition's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.